Graduated in Biological Sciences from the Federal University of Rio Grande do Sul (1995), with a Master's degree in Biological Sciences (Cardiovascular Physiology) from the same institution (1999), and a Ph.D. in Sciences (Nephrology) from the São Paulo School of Medicine, UNIFESP (2004).Professor and Researcher affiliated with the Laboratory of Renal and Cardiovascular Metabolic Physiopharmacology and the Histology Laboratory at Mackenzie Presbyterian University, with experience in Physiology, focusing on Cardiovascular and Renal Physiology, particularly in the following areas of experimental research: obesity and renal disease.Co-founder of ZF HealthTech, a company dedicated to innovation in the healthcare field. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
In Brazil, there has been a significant increase in companies dedicated to research, development, and innovation (R&D&I) to discover new molecules with therapeutic properties. According to "Valor Inovação Brasil 2023," the five largest pharmaceutical companies (Aché, Eurofarma, Roche, Hypera Pharma, and ABBVIE) invested more than R$1.8 billion in R&D&I for new "hits" or "leads" molecules …
Cardiovascular diseases (CVD) are the leaders in mortality in Brazil, with about 14 million Brazilians having some vascular or heart disease, contributing with about 30% of all deaths in the country. There are about a thousand deaths per day, numbers that are also associated with the Covid-19 pandemic, showing that this is a matter of absolute relevance to public health. Another aspect, i…
| 1 / 1 | Ongoing grants |
| 1 / 1 | Completed research grants |
| 1 / 0 | Completed scholarships in Brazil |
| 3 / 2 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID